Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974)

Abstract

Telcagepant inhibits the increases in DBF induced by the topical application of capsaicin on the human forearm. This experimental medicine model may have utility to assist in dose selection for the development of CGRP receptor antagonists.

References

Page 1

	Year	Citations
Calcitonin gene-related peptide is a potent vasodilator Susan D. Brain, T.J. Williams, John R. Tippins, Nature Molecular PhysiologySignal TransductionBiochemistryPhysiologyNeuropeptide Receptor	1985	2.1K
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache Peter J. Goadsby, Lars Edvinsson, Rolf Ekman Annals of Neurology	1990	1.6K
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine Jes Olesen, Hans‐Christoph Diener, Ingo W. Husstedt, New England Journal of Medicine	2004	1.2K
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Tony W. Ho, Michel D. Ferrari, David W. Dodick, The Lancet Cluster HeadacheMedicinePharmacotherapyAcute MigraineNeurology	2008	524
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist Henri Doods, Gerhard Hallermayer, Dongmei Wu, British Journal of Pharmacology	2000	467
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Tony W. Ho, L. K. Mannix, Xiaoyin Fan, Neurology	2007	461
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat Lars Edvinsson, Bertil B. Fredholm, Édith Hamel, Neuroscience Letters Endothelium-derived Relaxing FactorCerebral Vascular RegulationNeuropeptidesNeurophysiologyNeuroanatomy	1985	374
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects Rolf Uddman, Lars Edvinsson, Eva Ekblad, Regulatory Peptides Molecular PhysiologySignal TransductionBiochemistryPhysiologyNeuropeptide Receptor	1986	326
The CGRP-Antagonist, BIBN4096BS Does not Affect Cerebral or Systemic Haemodynamics in Healthy Volunteers Steffen Birk, LH Lassen, Christina Kruuse, Cephalalgia	2005	180
Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of <i>N</i> -[(3 <i>R</i> ,6 <i>S</i> )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 <i>H</i> -imidazo[4,5- <i>b</i> ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974) Daniel V. Paone, Anthony W. Shaw, Diem N. Nguyen, Journal of Medicinal Chemistry	2007	146

Page 1